Bibliography
Braunwald, E., Califf, R. M., Cannon, C. P., Fox, K. A. A., Fuster, V., Gibler, W. B., Harrington, R. A., King, S. B., Kleiman, N. S., Theroux, P., Topol, E. J., Van de Werf, F., White, H. D., & Willerson, J. T. (2000). Redefining medical treatment in the management of unstable angina. The American Journal of Medicine, 108(1), 41â53.
Authors
14
- Eugene Braunwald (first)
- Robert M Califf (additional)
- Christopher P Cannon (additional)
- Keith A.A Fox (additional)
- Valentin Fuster (additional)
- W.Brian Gibler (additional)
- Richard A Harrington (additional)
- Spencer B King (additional)
- Neil S Kleiman (additional)
- Pierre Theroux (additional)
- Eric J Topol (additional)
- Frans Van de Werf (additional)
- Harvey D White (additional)
- James T Willerson (additional)
References
96
Referenced
40
- Detailed diagnoses, and procedures, National Hospital Discharge Survey. National Center for Health Statistics. Vital Health Stat 1998;1996:13:138.
10.1161/01.CIR.98.21.2219
/ Circulation / Unstable angina by Braunwald (1998)10.1161/01.CIR.89.4.1545
/ Circulation / Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non–Q-wave myocardial infarction (1994)10.1056/NEJM199609123351103
/ NEJM / A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes (1996)10.1056/NEJM199708143370702
/ NEJM / A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease by Cohen (1997)10.1056/NEJM199805213382103
/ NEJM / A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina (1998)10.1056/NEJM199805213382102
/ NEJM / Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non–Q-wave myocardial infarction (1998)10.1056/NEJM199808133390704
/ NEJM / Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes (1998)10.1016/S0002-9149(98)00136-2
/ Am J Cardiol / Direct medical costs of coronary artery disease in the United States by Russell (1998)10.1161/01.CIR.98.18.1860
/ Circulation / Acute coronary syndromes in the GUSTO-IIb trial by Armstrong (1998)10.1097/00019501-199809110-00007
/ Cor Art Dis / The clinical course of patients with acute myocardial infarction who are unsuitable for thrombolytic therapy because of the presenting electrocardiogram by Wong (1998)10.1161/01.CIR.90.1.613
/ Circulation / Diagnosing and managing unstable angina by Braunwald (1994)- Agency for Health Care Policy, and Research. Braunwald E, Brown J, Brown L, et al. Diagnosing and managing unstable angina. Quick reference guide for clinicians, number 10. Rockville, MD: US Dept of Health and Human Services, 1994.
10.1161/01.CIR.80.2.410
/ Circulation / Unstable angina by Braunwald (1989)10.1016/0735-1097(95)00009-S
/ J Am Coll Cardiol / Incidence and follow-up of Braunwald subgoups in unstable angina pectoris by van Miltenburg-van Zijl (1995)10.1016/S0735-1097(98)00140-5
/ J Am Coll Cardiol / Unstable angina by van Domburg (1998)10.1001/jama.1995.03520260058033
/ JAMA / Risk stratification in unstable angina. Prospective validation of the Braunwald classification by Calvin (1995)10.1016/0002-9149(93)90349-H
/ Am J Cardiol / Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina by Ahmed (1993)10.1016/S0735-1097(96)00560-8
/ J Am Coll Cardiol / Correlation of angiographic morphology and clinical presentation in unstable angina by Dangas (1997)10.1016/S0002-9149(96)90581-0
/ Am J Cardiol / Correlation between clinical and morphologic findings in unstable angina by De Servi (1996)10.1093/oxfordjournals.eurheartj.a060773
/ Eur Heart J / Clinical predictors of unstable coronary lesion morphology by Rupprecht (1995)10.1177/000331979704800801
/ Angiology / Predictive validity of the Braunwald classification of unstable angina for angiographic findings, short-term prognoses, and treatment selection by Owa (1997)10.1016/0735-1097(88)90160-X
/ J Am Coll Cardiol / Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease by Califf (1988)10.1002/clc.4960121102
/ Clin Cardiol / Pathophysiology and management of unstable angina by Conti (1989)10.1016/0002-9149(89)90829-1
/ Am J Cardiol / Risk of adverse outcome in patients admitted to the coronary care unit with suspected unstable angina pectoris by Wilcox (1989)10.1136/hrt.67.5.395
/ Br Heart J / Predictors of risk in patients with unstable angina admitted to a district general hospital by Murphy (1992)10.1002/clc.4960160207
/ Clin Cardiol / Unstable angina by Bertolet (1993)10.1016/S0002-9149(99)80710-3
/ Am J Cardiol / A new clinical classification for hospital prognosis of unstable angina pectoris by Rizik (1995)10.1056/NEJM199806183382501
/ NEJM / Outcomes in patients with acute non–Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy by Boden (1998)10.1016/S0140-6736(97)11162-X
/ Lancet / Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation by Yusuf (1998)-
The FRISC II Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multicentre study. Lancet. 1999;354:708–715.
(
10.1016/S0140-6736(99)07349-3
) 10.1016/S0002-9149(98)00540-2
/ Am J Cardiol / Invasive versus conservative strategies in unstable angina and non-Q- wave myocardial infarction following treatment with tirofiban by Cannon (1998)10.1161/01.CIR.93.9.1651
/ Circulation / Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease by Lindahl (1996)10.1056/NEJM199610313351801
/ NEJM / Cardiac troponin T levels for risk stratification in acute myocardial ischemia by Ohman (1996)10.1056/NEJM199610313351802
/ NEJM / Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes by Antman (1996)10.1056/NEJM199712043372302
/ NEJM / Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I by Hamm (1997)10.1056/NEJM199610313351809
/ NEJM / Cardiac troponins in acute coronary syndromes by Van de Werf (1996)10.1093/clinchem/38.11.2203
/ Clin Chem / Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction by Bodor (1992)10.1093/clinchem/38.3.386
/ Clin Chem / Development and in vitro characterization of a new immunoassay of cardiac troponin T by Katus (1992)10.1056/NEJM199207163270302
/ NEJM / The prognostic value of serum troponin T in unstable angina by Hamm (1992)10.3109/00365519309092571
/ Scand J Clin Lab Invest / Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction by Ravkilde (1993)10.1016/0735-1097(94)00430-X
/ J Am Coll Cardiol / Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients by Ravkilde (1995)10.1016/S0002-9149(99)80274-4
/ Am J Cardiol / Prognostic value of cardiac troponin T in unstable angina pectoris by Wu (1995)10.1161/01.CIR.98.18.1853
/ Circulation / Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes by Newby (1998){'key': '10.1016/S0002-9343(99)00416-7_BIB45', 'first-page': '494', 'article-title': 'Cardiac troponin T, and cardiac troponin I', 'volume': '44', 'author': 'Christenson', 'year': '1998', 'journal-title': 'Clin Chem'}
/ Clin Chem / Cardiac troponin T, and cardiac troponin I by Christenson (1998)10.1016/S0002-9149(98)00200-8
/ Am J Cardiol / Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies by Olatidoye (1998)10.1016/S0735-1097(97)00485-3
/ J Am Coll Cardiol / Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes by Antman (1998)10.1056/NEJM199905273402103
/ NEJM / Benefit of of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators by Hamm (1999){'key': '10.1016/S0002-9343(99)00416-7_BIB49', 'first-page': 'N51', 'article-title': 'The FRISC experience with troponin T', 'volume': '19', 'author': 'Lindahl', 'year': '1998', 'journal-title': 'Eur Heart J'}
/ Eur Heart J / The FRISC experience with troponin T by Lindahl (1998)-
Hamm CW, Heeschen C, Goldmann B, et al. Troponin T predicts the benefit of abciximab in patients with unstable angina in the CAPTURE study. Eur Heart J. 1998;19(abstr suppl):117. Abstract.
(
10.1016/S0735-1097(98)81446-0
) 10.1136/hrt.47.3.239
/ Br Heart J / Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction by de Beer (1982)10.1016/0002-9149(90)90079-G
/ Am J Cardiol / Elevation of C-reactive protein in “active” coronary artery disease by Berk (1990)10.1056/NEJM199408183310701
/ NEJM / The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina by Liuzzo (1994)10.1016/S0140-6736(96)07591-5
/ Lancet / Production of C-reactive protein, and risk of coronary events in stable, and unstable angina by Haverkate (1997)10.1161/01.CIR.96.12.4204
/ Circulation / Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease by Toss (1997)10.1016/S0735-1097(98)00136-3
/ J Am Coll Cardiol / C-reactive protein is a potent predictor of mortality independently of, and in combination with troponin T in acute coronary syndromes. TIMI 11A substudy by Morrow (1998)10.1016/S0002-9149(97)00593-6
/ Am J Cardiol / C-reactive protein elevation, and early outcome in patients with unstable angina pectoris by Oltrona (1997)10.1161/01.CIR.98.4.294
/ Circulation / Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease by Montalescot (1998)10.1002/clc.4960190506
/ Clin Cardiol / Antiplatelet and anticoagulant use after myocardial infarction by Almony (1996)10.1056/NEJM199207163270301
/ NEJM / Reactivation of unstable angina after the discontinuation of heparin by Theroux (1992)10.1056/NEJM199709043371007
/ NEJM / Low-molecular-weight heparins by Weitz (1997)10.1161/01.CIR.98.15.1575
/ Circulation / Low-molecular-weight heparin:a review of the results of recent studies of the treatment of venous thromboembolism and unstable angina by Hirsh (1998)- Weitz JI, Hirsh J. Overview of new developments in heparins, thrombin inhibitors, and other new and novel agents. In: Sasahara AA, Loscalzo J, eds. New Therapeutic Agents in Thrombosis and Thrombolysis. New York: Marcel Dekker, 1997:77–86.
10.1016/S0140-6736(96)10452-9
/ Lancet / Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina (1997)10.1016/S0140-6736(96)91270-2
/ Lancet / Low-molecular-weight heparin during instability in coronary artery disease (1996)10.1016/S0002-9149(96)00744-8
/ Am J Cardiol / Comparison of heparin therapy for 48 hours to >48 hours in unstable angina pectoris by Klein (1997)- Leizorovicz A. The FRAXIS study. XXth Congress of the European Society of Cardiology, Vienna, Austria, August 1998:25.
-
Cohen M, Bigonzi F, Le Iouer V, et al. One year follow-up of the ESSENCE trial (enoxaparin versus heparin in unstable angina and non–Q-wave myocardial infarction). J Am Coll Cardiol 1998;31(suppl A):79A. Abstract.
(
10.1016/S0735-1097(97)84049-1
) -
Antman EM, McCabe CH, Premmereur J, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non–Q-wave myocardial infarction: results of Thrombolysis is Myocardial Infarction (TIMI) 11B Trial. Circulation. 1999;100:1593–1601.
(
10.1161/01.CIR.100.15.1593
) -
Antman EM, Cohen M, Radley D, et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q wave myocardial infarction: TIMI 11B ESSENCE Meta-Analysis. Circulation. 1999;100:1602–1608.
(
10.1161/01.CIR.100.15.1602
) -
Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Lancet 1999;353:429–438.
(
10.1016/S0140-6736(98)07332-2
) 10.1161/01.CIR.97.2.211
/ Circulation / Toward a new frontier in myocardial reperfusion therapy by Topol (1998)10.1161/01.CIR.90.4.1757
/ Circulation / Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty by Tcheng (1994)10.1016/S0002-9149(99)80345-2
/ Am J Cardiol / Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention by Harrington (1995)10.1016/0735-1097(95)00500-5
/ J Am Coll Cardiol / Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty by Kereiakes (1996){'key': '10.1016/S0002-9343(99)00416-7_BIB76', 'series-title': 'New Therapeutic Agents in Thrombosis and Thrombolysis', 'first-page': '333', 'article-title': 'Integrilin', 'author': 'Tardiff', 'year': '1997'}
/ New Therapeutic Agents in Thrombosis and Thrombolysis / Integrilin by Tardiff (1997)- Deckelbaum LI, Sax FL, Grossman W. Tirofiban, a nonpeptide inhibitor of the platelet glycoprotein IIb/IIIa receptor. In: Sasahara AA, Loscalzo J, eds. New Therapeutic Agents in Thrombosis and Thrombolysis. New York: Marcel Dekker, 1997:355–365.
10.1172/JCI119307
/ J Clin Invest / Platelet GPIIb/IIIa antagonists. The first anti-integrin receptor therapeutics by Coller (1997)10.1161/01.ATV.17.3.528
/ Arterioscler Thromb Vasc Biol / 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1, and blocks adhesion to fibrinogen, and ICAM-1 by Simon (1997)-
Barr E, Snapinn SM, Sax FL, Theroux P. Improved long-term clinical outcomes in unstable angina-patients undergoing coronary angioplasty following therapy with tirofiban and heparin. J Am Coll Cardiol 1998;31(suppl A):55A. Abstract.
(
10.1016/S0735-1097(97)83947-2
) -
Hahn SS, Chae C, Giugliano R, et al. Troponin I levels in unstable angina/non–Q-wave myocardial infarction patients treated with tirofiban, a glycoprotein IIb/IIIa antagonist. J Am Coll Cardiol. 1998;31(suppl A):229A. Abstract.
(
10.1016/S0735-1097(97)84701-8
) 10.1161/01.CIR.99.22.2892
/ Circulation / Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome by McClure (1999)10.1056/NEJM199404073301402
/ NEJM / Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty (1994)10.1056/NEJM199706123362401
/ NEJM / Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization (1997)10.1016/S0140-6736(98)85010-1
/ Lancet / Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade (1998){'key': '10.1016/S0002-9343(99)00416-7_BIB86', 'first-page': '1422', 'volume': '349', 'year': '1997', 'journal-title': 'Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Lancet'}
/ Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Lancet (1997)10.1161/01.CIR.96.5.1445
/ Circulation / Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty (1997)10.1161/01.CIR.97.4.340
/ Circulation / Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome by Cannon (1998)10.1161/01.CIR.98.13.1268
/ Circulation / Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa receptor blockade with oral xemilofiban by Kereiakes (1998)-
Ferguson JJ, Deedwania PC, Kereiakes DJ, et al. Sustained platelet GP IIb/IIIa blockade with oral orbofiban: interim pharmacodynamic results of the SOAR study. J Am Coll Cardiol 1998;31(suppl A):185A. Abstract.
(
10.1016/S0735-1097(97)84509-3
) -
Deedwania PC, Ferguson JJ, Kereiakes DJ, et al. Sustained platelet GP IIb/IIIa blockade with oral orbofiban: interim safety and tolerability results of the SOAR study. J Am Coll Cardiol 1998;31(suppl A):94A. Abstract.
(
10.1016/S0735-1097(97)84112-5
) 10.1161/01.CIR.96.11.3860
/ Circulation / Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy by Mascelli (1997)10.1161/01.CIR.97.1.5
/ Circulation / Monitoring platelet GP IIb/IIIa antagonist therapy by Coller (1998)- O’Neill W. Results of the EXCITE trial. 48th Annual Scientific Ses-sions, American College of Cardiology, New Orleans, Louisiana, March 7, 1999.
- Cannon C. Results of the OPUS-TIMI 16 trial. 48th Annual Scientific Sessions, American College of Cardiology, New Orleans, Louisiana, March 10, 1999.
- Topol E. Results of the SYMPHONY trial. XXI Congress of the European Society of Cardiology, Barcelona, September 1, 1999.
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 25, 2002, 8:40 p.m.) |
Deposited | 5 years, 7 months ago (Feb. 4, 2020, 1:38 p.m.) |
Indexed | 2 months ago (July 1, 2025, 12:29 p.m.) |
Issued | 25 years, 8 months ago (Jan. 1, 2000) |
Published | 25 years, 8 months ago (Jan. 1, 2000) |
Published Print | 25 years, 8 months ago (Jan. 1, 2000) |
@article{Braunwald_2000, title={Redefining medical treatment in the management of unstable angina}, volume={108}, ISSN={0002-9343}, url={http://dx.doi.org/10.1016/s0002-9343(99)00416-7}, DOI={10.1016/s0002-9343(99)00416-7}, number={1}, journal={The American Journal of Medicine}, publisher={Elsevier BV}, author={Braunwald, Eugene and Califf, Robert M and Cannon, Christopher P and Fox, Keith A.A and Fuster, Valentin and Gibler, W.Brian and Harrington, Richard A and King, Spencer B and Kleiman, Neil S and Theroux, Pierre and Topol, Eric J and Van de Werf, Frans and White, Harvey D and Willerson, James T}, year={2000}, month=jan, pages={41–53} }